Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets.
about
CD40 in coronary artery disease: a matter of macrophages?The central role of platelet activation in determining the severity of acute coronary syndromesEnhanced levels of CD154 (CD40 ligand) on platelets in patients with chronic heart failureIncreased platelet CD63 and P-selectin expression persist in atherosclerotic ischemic strokeClinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic diseaseFlow Cytometric Investigation of Classical and Alternative Platelet Activation Markers.Circulating soluble CD40 ligand mediates the interaction between neutrophils and platelets in acute coronary syndrome.CD40L and Its Receptors in Atherothrombosis-An UpdateThe levels of soluble CD40 ligand and C-reactive protein in normal weight, overweight and obese people.Vascular effects of ultrafine particles in persons with type 2 diabetesPrognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count.The roles of buyang huanwu decoction in anti-inflammation, antioxidation and regulation of lipid metabolism in rats with myocardial ischemia.Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients.CD40 ligand: a novel target in the fight against cardiovascular disease.Novel uses for anti-platelet agents as anti-inflammatory drugs.Biomarkers in acute coronary syndromes and their role in diabetic patients.Soluble CD40 ligand induces beta3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling.Developmental changes in soluble CD40 ligand.Platelet hyperfunction as risk factor for chronic and acute coronary events.The CD40-CD40L system in cardiovascular disease.CD40-CD40L: linking pancreatic, adipose tissue and vascular inflammation in type 2 diabetes and its complications.The tumor necrosis factor superfamily in heart failure.The use of MCP-1 and soluble CD40 ligand in a pathophysiology-guided approach to the management of coronary artery disease.Expression of EMMPRIN (CD147) on circulating platelets in vivo.Effect of statins on soluble CD40 ligand in hypercholesterolemic Type 2 diabetic patients.Platelet and monocyte activation in acute ischemic stroke--is there a correlation with stroke etiology?Platelet count predicts cardiovascular mortality in very elderly patients with myocardial infarction.Platelet CD40 contributes to enhanced monocyte chemoattractant protein 1 levels in patients with resistant hypertension.β1-Adrenoceptor antibody-induced increase in soluble CD40 ligand release in chronic periodontitis patients: role of prostaglandin E(2).
P2860
Q26752784-F372FBC9-8860-42B6-94C5-C9C5B983F557Q28165330-880F03E7-F2B2-4016-A9CF-5151F711EB05Q28166019-31FB2344-0456-43AD-9993-BC213353FD0CQ28167456-1134B7E3-7560-4A20-84C1-A8D37B06C515Q28218124-01D52F00-B0EB-4ABA-BC6C-1300FF15EFC0Q33435650-3FEF60B4-D876-46C2-ABAA-965F429CDABDQ33646945-80D9F742-2969-4770-AB7D-58D8F76E00DAQ33814059-5ABEA7FF-F497-4025-B658-C27432B4E78FQ34020389-3D80B6E4-1146-4AB2-B9F4-21BF520BD589Q34407458-77B33F91-65A4-450F-A80C-892F745F1F94Q34779205-0328BAFB-B1DD-4152-829C-45AFE37C7571Q35106421-9F0A5984-E750-45B2-94A3-863935650546Q35596004-45ABC6AB-C7CC-4982-B6EB-1E8BA3411A50Q35848866-931D8F7F-52E2-4E9D-87BD-1BD6876D0B9DQ36171374-E0579CB4-AC8F-4231-8F83-40B91A5E745FQ36333917-BA3273ED-37E7-4DDD-9C80-C136A6159314Q36350146-3E5904F1-CA6A-4D69-AC71-96C95918C52BQ36948507-03ECC546-460A-40FA-939C-722700CDDD64Q37658732-B9BC6BD8-B5D1-46B0-8EBC-B8D882AA8963Q37829738-FA381862-EF9F-4884-BBD5-BF6D68996B44Q38042321-052CD57F-2FDB-4755-80DD-6771AD19D9D3Q40361542-91A8C371-539C-4E5D-AB0E-DEA3E7FEB12BQ40393639-259533A9-E042-46C1-8DE2-3555BBB8455EQ43227478-7665A80B-73BB-4E92-BA73-AA6EEEB7E96BQ46372426-0472E2D6-7536-48D8-BFEE-2EAF97D70965Q49082878-D51E19AA-035C-4A13-8674-74C8677F8C53Q53120736-E171043B-95C9-4588-B1FE-BFCFE9533E3CQ53704529-E6EFEA16-11B4-4019-BDAC-69D28BF711EAQ54539813-471CA44A-1ED5-43ED-884A-CD47C12815AE
P2860
Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets.
@ast
Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets.
@en
type
label
Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets.
@ast
Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets.
@en
prefLabel
Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets.
@ast
Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets.
@en
P2093
P2860
P356
P1433
P1476
Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets
@en
P2093
A Schmeisser
C D Garlichs
M Herrmann
W G Daniel
P2860
P304
P356
10.1136/HEART.86.6.649
P407
P577
2001-12-01T00:00:00Z